{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:36:59Z","timestamp":1791283019876,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12985-015-0266-8","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T15:03:52Z","timestamp":1425567832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection"],"prefix":"10.1186","volume":"12","author":[{"given":"Irene","family":"Guendel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix W","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M","family":"Dever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Valerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylene","family":"Kehn-Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1054-3589(07)55004-0","volume":"55","author":"A Gatignol","year":"2007","unstructured":"Gatignol A. Transcription of HIV: Tat and cellular chromatin. Adv Pharmacol. 2007;55:137\u201359.","journal-title":"Adv Pharmacol"},{"key":"266_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1101\/gad.12.5.755","volume":"12","author":"J Peng","year":"1998","unstructured":"Peng J, Zhu Y, Milton JT, Price DH. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 1998;12:755\u201362.","journal-title":"Genes Dev"},{"key":"266_CR3","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1128\/JVI.72.9.7154-7159.1998","volume":"72","author":"K Fujinaga","year":"1998","unstructured":"Fujinaga K, Cujec TP, Peng J, Garriga J, Price DH, Grana X, et al. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J Virol. 1998;72:7154\u20139.","journal-title":"J Virol"},{"key":"266_CR4","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/jvi.69.3.1612-1620.1995","volume":"69","author":"CH Herrmann","year":"1995","unstructured":"Herrmann CH, Rice AP. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J Virol. 1995;69:1612\u201320.","journal-title":"J Virol"},{"key":"266_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0092-8674(89)90290-0","volume":"59","author":"MF Laspia","year":"1989","unstructured":"Laspia MF, Rice AP, Mathews MB. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 1989;59:283\u201392.","journal-title":"Cell"},{"key":"266_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/326711a0","volume":"326","author":"G Nabel","year":"1987","unstructured":"Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 1987;326:711\u20133.","journal-title":"Nature"},{"key":"266_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molcel.2010.04.012","volume":"38","author":"B Sobhian","year":"2010","unstructured":"Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell. 2010;38:439\u201351.","journal-title":"Mol Cell"},{"key":"266_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1101\/sqb.1998.63.371","volume":"63","author":"ME Garber","year":"1998","unstructured":"Garber ME, Wei P, Jones KA. HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harb Symp Quant Biol. 1998;63:371\u201380.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"266_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0092-8674(00)80939-3","volume":"92","author":"P Wei","year":"1998","unstructured":"Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998;92:451\u201362.","journal-title":"Cell"},{"key":"266_CR10","doi-asserted-by":"publisher","first-page":"13522","DOI":"10.1128\/JVI.78.24.13522-13533.2004","volume":"78","author":"M Zhou","year":"2004","unstructured":"Zhou M, Deng L, Lacoste V, Park HU, Pumfery A, Kashanchi F, et al. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription. J Virol. 2004;78:13522\u201333.","journal-title":"J Virol"},{"key":"266_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.cdd.4401565","volume":"12","author":"JL Andersen","year":"2005","unstructured":"Andersen JL, Zimmerman ES, DeHart JL, Murala S, Ardon O, Blackett J, et al. ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis. Cell Death Differ. 2005;12:326\u201334.","journal-title":"Cell Death Differ"},{"key":"266_CR12","doi-asserted-by":"publisher","first-page":"11477","DOI":"10.1128\/JVI.78.21.11477-11486.2004","volume":"78","author":"CR Coberley","year":"2004","unstructured":"Coberley CR, Kohler JJ, Brown JN, Oshier JT, Baker HV, Popp MP, et al. Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1. J Virol. 2004;78:11477\u201386.","journal-title":"J Virol"},{"key":"266_CR13","doi-asserted-by":"publisher","first-page":"9286","DOI":"10.1128\/MCB.24.21.9286-9294.2004","volume":"24","author":"ES Zimmerman","year":"2004","unstructured":"Zimmerman ES, Chen J, Andersen JL, Ardon O, Dehart JL, Blackett J, et al. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. Mol Cell Biol. 2004;24:9286\u201394.","journal-title":"Mol Cell Biol"},{"key":"266_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.virol.2009.10.032","volume":"396","author":"YX Yang","year":"2010","unstructured":"Yang YX, Guen V, Richard J, Cohen EA, Berthoux L. Cell context-dependent involvement of ATR in early stages of retroviral replication. Virology. 2010;396:272\u20139.","journal-title":"Virology"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1101\/gad.225045.113","volume":"27","author":"SD Dimitrov","year":"2013","unstructured":"Dimitrov SD, Lu D, Naetar N, Hu Y, Pathania S, Kanellopoulou C, et al. Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle. Genes Dev. 2013;27:2274\u201391.","journal-title":"Genes Dev"},{"key":"266_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/0008-5472.CAN-09-1477","volume":"70","author":"A De Siervi","year":"2010","unstructured":"De Siervi A, De Luca P, Byun JS, Di LJ, Fufa T, Haggerty CM, et al. Transcriptional autoregulation by BRCA1. Cancer Res. 2010;70:532\u201342.","journal-title":"Cancer Res"},{"key":"266_CR17","doi-asserted-by":"publisher","first-page":"13595","DOI":"10.1073\/pnas.93.24.13595","volume":"93","author":"AN Monteiro","year":"1996","unstructured":"Monteiro AN, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A. 1996;93:13595\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.tibs.2004.09.010","volume":"29","author":"JN Glover","year":"2004","unstructured":"Glover JN, Williams RS, Lee MS. Interactions between BRCT repeats and phosphoproteins: tangled up in two. Trends Biochem Sci. 2004;29:579\u201385.","journal-title":"Trends Biochem Sci"},{"key":"266_CR19","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1073\/pnas.94.11.5605","volume":"94","author":"R Scully","year":"1997","unstructured":"Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A. 1997;94:5605\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266_CR20","doi-asserted-by":"publisher","first-page":"52012","DOI":"10.1074\/jbc.M308418200","volume":"278","author":"SA Krum","year":"2003","unstructured":"Krum SA, Miranda GA, Lin C, Lane TF. BRCA1 associates with processive RNA polymerase II. J Biol Chem. 2003;278:52012\u201320.","journal-title":"J Biol Chem"},{"key":"266_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/930","volume":"19","author":"SF Anderson","year":"1998","unstructured":"Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet. 1998;19:254\u20136.","journal-title":"Nat Genet"},{"key":"266_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1073\/pnas.97.3.1020","volume":"97","author":"GM Pao","year":"2000","unstructured":"Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. CBP\/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A. 2000;97:1020\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcp.10257","volume":"196","author":"EM Rosen","year":"2003","unstructured":"Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol. 2003;196:19\u201341.","journal-title":"J Cell Physiol"},{"key":"266_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0092-8674(00)80769-2","volume":"97","author":"DP Harkin","year":"1999","unstructured":"Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, et al. Induction of GADD45 and JNK\/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 1999;97:575\u201386.","journal-title":"Cell"},{"key":"266_CR25","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1038\/sj.onc.1203759","volume":"19","author":"S Jin","year":"2000","unstructured":"Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, et al. BRCA1 activation of the GADD45 promoter. Oncogene. 2000;19:4050\u20137.","journal-title":"Oncogene"},{"key":"266_CR26","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1073\/pnas.95.5.2302","volume":"95","author":"T Ouchi","year":"1998","unstructured":"Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A. 1998;95:2302\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jcb.10469","volume":"88","author":"K Somasundaram","year":"2003","unstructured":"Somasundaram K. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair\u2013perhaps through transcription. J Cell Biochem. 2003;88:1084\u201391.","journal-title":"J Cell Biochem"},{"key":"266_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/38291","volume":"389","author":"K Somasundaram","year":"1997","unstructured":"Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1\/CiP1. Nature. 1997;389:187\u201390.","journal-title":"Nature"},{"key":"266_CR29","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/sj.onc.1205461","volume":"21","author":"EA Williamson","year":"2002","unstructured":"Williamson EA, Dadmanesh F, Koeffler HP. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene. 2002;21:3199\u2013206.","journal-title":"Oncogene"},{"key":"266_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.onc.1201932","volume":"16","author":"H Zhang","year":"1998","unstructured":"Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 1998;16:1713\u201321.","journal-title":"Oncogene"},{"key":"266_CR31","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1038\/sj.onc.1207684","volume":"23","author":"P Cabart","year":"2004","unstructured":"Cabart P, Chew HK, Murphy S. BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II. Oncogene. 2004;23:5316\u201329.","journal-title":"Oncogene"},{"key":"266_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(00)00030-1","volume":"102","author":"DA Bochar","year":"2000","unstructured":"Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, et al. BRCA1 is associated with a human SWI\/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 2000;102:257\u201365.","journal-title":"Cell"},{"key":"266_CR33","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1158\/0008-5472.CAN-09-2089","volume":"70","author":"MT Harte","year":"2010","unstructured":"Harte MT, O\u2019Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, et al. BRD7, a subunit of SWI\/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res. 2010;70:2538\u201347.","journal-title":"Cancer Res"},{"key":"266_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1083\/jcb.201001160","volume":"191","author":"Y Xu","year":"2010","unstructured":"Xu Y, Sun Y, Jiang X, Ayrapetov MK, Moskwa P, Yang S, et al. The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J Cell Biol. 2010;191:31\u201343.","journal-title":"J Cell Biol"},{"key":"266_CR35","first-page":"7","volume":"3","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chen H, Gong M, Gong F. The chromatin remodeling protein BRG1 modulates BRCA1 response to UV irradiation by regulating ATR\/ATM activation. Front Oncol. 2013;3:7.","journal-title":"Front Oncol"},{"key":"266_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.4161\/cc.24986","volume":"12","author":"Z Tu","year":"2013","unstructured":"Tu Z, Aird KM, Zhang R. Chromatin remodeling, BRCA1, SAHF and cellular senescence. Cell Cycle. 2013;12:1653\u20134.","journal-title":"Cell Cycle"},{"key":"266_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66\u201371.","journal-title":"Science"},{"key":"266_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1083\/jcb.201110008","volume":"197","author":"S Kawai","year":"2012","unstructured":"Kawai S, Amano A. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol. 2012;197:201\u20138.","journal-title":"J Cell Biol"},{"key":"266_CR39","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1073\/pnas.96.9.4983","volume":"96","author":"RI Yarden","year":"1999","unstructured":"Yarden RI, Brody LC. BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci U S A. 1999;96:4983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/1541-7786.MCR-06-0234","volume":"5","author":"C DelloRusso","year":"2007","unstructured":"DelloRusso C, Welcsh PL, Wang W, Garcia RL, King MC, Swisher EM. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol Cancer Res. 2007;5:35\u201345.","journal-title":"Mol Cancer Res"},{"key":"266_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.016303-0","volume":"91","author":"B Romani","year":"2010","unstructured":"Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol. 2010;91:1\u201312.","journal-title":"J Gen Virol"},{"key":"266_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1126\/science.2832944","volume":"240","author":"AD Frankel","year":"1988","unstructured":"Frankel AD, Bredt DS, Pabo CO. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science. 1988;240:70\u20133.","journal-title":"Science"},{"key":"266_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrm2831","volume":"11","author":"MS Huen","year":"2010","unstructured":"Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol. 2010;11:138\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"266_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1128\/JVI.74.2.652-660.2000","volume":"74","author":"F Kashanchi","year":"2000","unstructured":"Kashanchi F, Agbottah ET, Pise-Masison CA, Mahieux R, Duvall J, Kumar A, et al. Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator. J Virol. 2000;74:652\u201360.","journal-title":"J Virol"},{"key":"266_CR45","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/carcin\/bgt240","volume":"34","author":"H Ogiwara","year":"2013","unstructured":"Ogiwara H, Ui A, Shiotani B, Zou L, Yasui A, Kohno T. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor. Carcinogenesis. 2013;34:2486\u201397.","journal-title":"Carcinogenesis"},{"key":"266_CR46","first-page":"1","volume":"4","author":"Z Ji","year":"2010","unstructured":"Ji Z. Targeting DNA damage and repair by curcumin. Breast Cancer : Basic and Clin Res. 2010;4:1\u20133.","journal-title":"Breast Cancer : Basic and Clin Res"},{"key":"266_CR47","doi-asserted-by":"publisher","first-page":"33198","DOI":"10.1074\/jbc.M112.356535","volume":"287","author":"A Narayanan","year":"2012","unstructured":"Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, Guendel I, et al. Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem. 2012;287:33198\u2013214.","journal-title":"J Biol Chem"},{"key":"266_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejmech.2014.01.060","volume":"76C","author":"Y Bansal","year":"2014","unstructured":"Bansal Y, Silakari O. Multifunctional compounds: Smart molecules for multifactorial diseases. Eur J Med Chem. 2014;76C:31\u201342.","journal-title":"Eur J Med Chem"},{"key":"266_CR49","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.3390\/molecules18055389","volume":"18","author":"KS Bhullar","year":"2013","unstructured":"Bhullar KS, Jha A, Youssef D, Rupasinghe HP. Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties. Molecules. 2013;18:5389\u2013404.","journal-title":"Molecules"},{"key":"266_CR50","first-page":"61","volume":"3","author":"DL Rowe","year":"2009","unstructured":"Rowe DL, Ozbay T, O\u2019Regan RM, Nahta R. Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin. Breast Cancer : Basic and Clin Res. 2009;3:61\u201375.","journal-title":"Breast Cancer : Basic and Clin Res"},{"key":"266_CR51","doi-asserted-by":"publisher","first-page":"e23388","DOI":"10.1371\/journal.pone.0023388","volume":"6","author":"U Gandapu","year":"2011","unstructured":"Gandapu U, Chaitanya RK, Kishore G, Reddy RC, Kondapi AK. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. PLoS One. 2011;6:e23388.","journal-title":"PLoS One"},{"key":"266_CR52","doi-asserted-by":"publisher","first-page":"e70565","DOI":"10.1371\/journal.pone.0070565","volume":"8","author":"L Guo","year":"2013","unstructured":"Guo L, Xing Y, Pan R, Jiang M, Gong Z, Lin L, et al. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis. PLoS One. 2013;8:e70565.","journal-title":"PLoS One"},{"key":"266_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2009.03.013","volume":"85","author":"H Tang","year":"2009","unstructured":"Tang H, Lu D, Pan R, Qin X, Xiong H, Dong J. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120\u00a0V3 loop peptide in rats. Life Sci. 2009;85:1\u201310.","journal-title":"Life Sci"},{"key":"266_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00705-007-0023-4","volume":"153","author":"DA Riva","year":"2008","unstructured":"Riva DA, Fernandez-Larrosa PN, Dolcini GL, Martinez-Peralta LA, Coulombie FC, Mersich SE. Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells. Arch Virol. 2008;153:561\u20135.","journal-title":"Arch Virol"},{"key":"266_CR55","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1002\/jcp.22691","volume":"226","author":"HS Zhang","year":"2011","unstructured":"Zhang HS, Ruan Z, Sang WW. HDAC1\/NFkappaB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. J Cell Physiol. 2011;226:3385\u201391.","journal-title":"J Cell Physiol"},{"key":"266_CR56","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/bies.20204","volume":"27","author":"A Traven","year":"2005","unstructured":"Traven A, Heierhorst J. SQ\/TQ cluster domains: concentrated ATM\/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays. 2005;27:397\u2013407.","journal-title":"Bioessays"},{"key":"266_CR57","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1101\/gad.851000","volume":"14","author":"RS Tibbetts","year":"2000","unstructured":"Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 2000;14:2989\u20133002.","journal-title":"Genes Dev"},{"key":"266_CR58","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1126\/science.286.5442.1162","volume":"286","author":"D Cortez","year":"1999","unstructured":"Cortez D, Wang Y, Qin J, Elledge SJ. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 1999;286:1162\u20136.","journal-title":"Science"},{"key":"266_CR59","first-page":"3299","volume":"60","author":"M Gatei","year":"2000","unstructured":"Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, et al. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 2000;60:3299\u2013304.","journal-title":"Cancer Res"},{"key":"266_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/35004614","volume":"404","author":"JS Lee","year":"2000","unstructured":"Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 2000;404:201\u20134.","journal-title":"Nature"},{"key":"266_CR61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/333078a0","volume":"333","author":"K Valerie","year":"1988","unstructured":"Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 1988;333:78\u201381.","journal-title":"Nature"},{"key":"266_CR62","doi-asserted-by":"publisher","first-page":"10342","DOI":"10.1074\/jbc.275.14.10342","volume":"275","author":"BB Zhou","year":"2000","unstructured":"Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, et al. Caffeine abolishes the mammalian G(2)\/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem. 2000;275:10342\u20138.","journal-title":"J Biol Chem"},{"key":"266_CR63","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004;64:9152\u20139.","journal-title":"Cancer Res"},{"key":"266_CR64","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1128\/MCB.24.2.708-718.2004","volume":"24","author":"J Zhang","year":"2004","unstructured":"Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, et al. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol. 2004;24:708\u201318.","journal-title":"Mol Cell Biol"},{"key":"266_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.virol.2005.02.015","volume":"335","author":"G Nunnari","year":"2005","unstructured":"Nunnari G, Argyris E, Fang J, Mehlman KE, Pomerantz RJ, Daniel R. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines. Virology. 2005;335:177\u201384.","journal-title":"Virology"},{"key":"266_CR66","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1128\/JVI.79.5.2973-2978.2005","volume":"79","author":"Y Ariumi","year":"2005","unstructured":"Ariumi Y, Turelli P, Masutani M, Trono D. DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration. J Virol. 2005;79:2973\u20138.","journal-title":"J Virol"},{"key":"266_CR67","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ncb1250","volume":"7","author":"A Lau","year":"2005","unstructured":"Lau A, Swinbank KM, Ahmed PS, Taylor DL, Jackson SP, Smith GC, et al. Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat Cell Biol. 2005;7:493\u2013500.","journal-title":"Nat Cell Biol"},{"key":"266_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-4690-10-21","volume":"10","author":"T Koyama","year":"2013","unstructured":"Koyama T, Sun B, Tokunaga K, Tatsumi M, Ishizaka Y. DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition. Retrovirology. 2013;10:21.","journal-title":"Retrovirology"},{"key":"266_CR69","doi-asserted-by":"publisher","first-page":"e11245","DOI":"10.1371\/journal.pone.0011245","volume":"5","author":"G Napolitano","year":"2010","unstructured":"Napolitano G, Amente S, Castiglia V, Gargano B, Ruda V, Darzacq X, et al. Caffeine prevents transcription inhibition and P-TEFb\/7SK dissociation following UV-induced DNA damage. PLoS One. 2010;5:e11245.","journal-title":"PLoS One"},{"key":"266_CR70","doi-asserted-by":"publisher","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","volume":"74","author":"CA Derdeyn","year":"2000","unstructured":"Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O\u2019Brien WA, Ratner L, et al. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol. 2000;74:8358\u201367.","journal-title":"J Virol"},{"key":"266_CR71","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","volume":"46","author":"X Wei","year":"2002","unstructured":"Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 2002;46:1896\u2013905.","journal-title":"Antimicrob Agents Chemother"},{"key":"266_CR72","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1097-2765(00)80238-5","volume":"4","author":"R Scully","year":"1999","unstructured":"Scully R, Ganesan S, Vlasakova K, Chen J, Socolovsky M, Livingston DM. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell. 1999;4:1093\u20139.","journal-title":"Mol Cell"},{"key":"266_CR73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.18632\/aging.100325","volume":"3","author":"SM Dever","year":"2011","unstructured":"Dever SM, Golding SE, Rosenberg E, Adams BR, Idowu MO, Quillin JM, et al. Mutations in the BRCT binding site of BRCA1 result in hyper-recombination. Aging. 2011;3:515\u201332.","journal-title":"Aging"},{"key":"266_CR74","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1073\/pnas.91.20.9564","volume":"91","author":"JK Yee","year":"1994","unstructured":"Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A. 1994;91:9564\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266_CR75","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263\u20137.","journal-title":"Science"},{"key":"266_CR76","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/gt.2010.53","volume":"17","author":"Z Wang","year":"2010","unstructured":"Wang Z, Tang Z, Zheng Y, Yu D, Spear M, Iyer SR, et al. Development of a nonintegrating Rev-dependent lentiviral vector carrying diphtheria toxin A chain and human TRAF6 to target HIV reservoirs. Gene Ther. 2010;17:1063\u201376.","journal-title":"Gene Ther"},{"key":"266_CR77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1742-4690-5-36","volume":"5","author":"J Young","year":"2008","unstructured":"Young J, Tang Z, Yu Q, Yu D, Wu Y. Selective killing of HIV-1-positive macrophages and T cells by the Rev-dependent lentivirus carrying anthrolysin O from Bacillus anthracis. Retrovirology. 2008;5:36.","journal-title":"Retrovirology"},{"key":"266_CR78","doi-asserted-by":"publisher","first-page":"e11379","DOI":"10.1371\/journal.pone.0011379","volume":"5","author":"I Guendel","year":"2010","unstructured":"Guendel I, Carpio L, Pedati C, Schwartz A, Teal C, Kashanchi F, et al. Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function. PLoS One. 2010;5:e11379.","journal-title":"PLoS One"},{"key":"266_CR79","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/hmg\/ddh260","volume":"13","author":"M Taron","year":"2004","unstructured":"Taron M, Rosell R, Felip E, Mendez P, Souglakos J, Ronco MS, et al. BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Hum Mol Genet. 2004;13:2443\u20139.","journal-title":"Hum Mol Genet"},{"key":"266_CR80","doi-asserted-by":"publisher","first-page":"18330","DOI":"10.1074\/jbc.M112.339317","volume":"287","author":"L Ai","year":"2012","unstructured":"Ai L, Skehan RR, Saydi J, Lin T, Brown KD. Ataxia-Telangiectasia, Mutated (ATM)\/Nuclear Factor kappa light chain enhancer of activated B cells (NFkappaB) signaling controls basal and DNA damage-induced transglutaminase 2 expression. J Biol Chem. 2012;287:18330\u201341.","journal-title":"J Biol Chem"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-015-0266-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0266-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:08:38Z","timestamp":1630573718000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-015-0266-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1186\/s12985-015-0266-8","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]},"assertion":[{"value":"25 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"40"}}